News Archives

News Archives

Avivagen Announces its Attendance at BIOSPAIN 2018

Ottawa, ON / TNW-Accesswire / September 24, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen), is pleased to announce that it will be attending BIOSPAIN 2018, in Seville, Spain, from September 25th-27th, 2018. Avivagen was invited to attend by the Department of Foreign Affairs, Trade & Development, Canada (DFATD) and is representing Canada with Mr. Kym …Read More

Avivagen Announces Follow-On Large Order from UNAHCO for OxC-beta™ Livestock

Ottawa, ON / TNW-Accesswire / September 20, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences Corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, is pleased to announce that its partner in the Philippines, …Read More

Avivagen Announces Approval from TSX Venture Exchange for Extension of Warrants

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Ottawa, ON – September 17, 2018 — Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products …Read More

Avivagen Announces Q3 Financial Results and Proposed Extension of Warrants

Ottawa, ON / TNW-Accesswire / September 5, 2018 / – – Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, today reported its financial results for Q3, 2018.  Unless otherwise …Read More

Avivagen Announces Vivamune Distribution Agreement for the GTA

Ottawa, ON / TNW-Accesswire / August 22, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, is pleased to announce that it has entered into a …Read More

Avivagen Announces Agreement to Terminate China JV

Ottawa, ON / TNW-Accesswire / August 07, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, announces that it has entered into an agreement that will …Read More